Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes (Q36328161)

13 August 2017

Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes (English)

1 reference

intraoperative radiation therapy

13 August 2017

0 references

1 reference

recurrent endometrial cancer

inferred from title

1 reference

2

Andrea Mariani

1 reference

13 August 2017

Sean C Dowdy

1

1 reference

13 August 2017

William A Cliby

3

1 reference

13 August 2017

Michael G Haddock

4

1 reference

13 August 2017

Ivy A Petersen

5

1 reference

13 August 2017

Franklin H Sim

6

1 reference

13 August 2017

Karl C Podratz

7

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

13 August 2017

1 reference

13 August 2017

101

1 reference

13 August 2017

280-286

1 reference

13 August 2017

2

1 reference

13 August 2017

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Isolated vaginal recurrences of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Treatment of vaginal recurrence in endometrial cancer. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Interstitial brachytherapy for vaginal recurrences of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Pelvic exenteration for recurrent endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Hormonal therapy in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Survival after relapse in patients with endometrial cancer: results from a randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Results of radiotherapy in recurrent endometrial carcinoma: a retrospective analysis of 51 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Intraoperative radiotherapy in recurrent gynecological cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

IORT for locally advanced gynecological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Rationale for and results of intraoperative radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Intraoperative radiation therapy in gynecologic cancer: update of the experience at a single institution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Intraoperative radiation therapy in gynecologic cancer: the Mayo Clinic experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Intraoperative radiation therapy in the management of gynecologic and genitourinary malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Intraoperative radiation therapy in the treatment of pelvic gynecologic malignancies: a review of fifteen cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

The role of intraoperative radiation therapy (IORT) in the treatment of locally advanced gynecologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Present and future of intraoperative radiation therapy (IORT). Keynote address

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

The use of intraoperative radiation therapy in radical salvage for recurrent cervical cancer: outcome and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Complications of intraoperative radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Endometrial cancer metastatic to infrarenal aortic lymph nodes unrecognized during laparoscopic inframesenteric aortic lymph node dissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

Predictors of lymphatic failure in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.018

10.1016/J.YGYNO.2005.10.018

7 January 2021

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7q2tbpz33jehdglfiz2wzeoqwm

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_7q2tbpz33jehdglfiz2wzeoqwm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7q2tbpz33jehdglfiz2wzeoqwm

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/7q2tbpz33jehdglfiz2wzeoqwm

30 July 2022